Among November’s prominent NFT sales, CryptoPunk #8407 has gained the 1st position. Hence, the respective NFT’s price hit the staggering 100 $ETH.Among November’s prominent NFT sales, CryptoPunk #8407 has gained the 1st position. Hence, the respective NFT’s price hit the staggering 100 $ETH.

CryptoPunks and BAYC Dominate Top NFT Sales of November 2025

nft-aii2 main

November 2025 has witnessed a considerable rise in NFT sales across the globe. In this respect, CryptoPunks and Bored Ape Yacht Club have emerged as the top-selling NFT collections of the month. As per the data from Phoenix Group, CryptoPunks have occupied 9 out of the top 10 monthly NFT sales. Additionally, this growth points toward a massive rise in investor interest in the NFT market.

CryptoPunk #8407 Leads November’s NFT Sales, Generating100 $ETH in Price

Specifically, among November’s prominent NFT sales, CryptoPunk #8407 has gained the 1st position. Hence, the respective NFT’s price hit the staggering 100 $ETH. This figure accounts for $414.57K in total. Subsequently, Bore Ape Yacht Club #3105 has attained the 2nd top spot among this month’s notable NFT sales. Thus, it has added 90 $ETH, underscoring $360.34K in terms of price.

Subsequently, CryptoPunk #3677 has become the 3rd top NFT when it comes to the latest monthly NFT sales. So, it reached the price of 78 $ETH, denoting $308.40K in the cumulative valuation. After that, CryptoPunk W#4350 has seen the 4th top rank on the list. Therefore, it has secured a total 62.9 $ETH, equaling $248.83K in the case of price.

Following that, the 5th top NFT sale of November is CryptoPunk #7378. Particularly, its final price was 51 $ETH. This reportedly equals an overall amount of almost $211.23K. The next top NFT sale includes CryptoPunk #9361, with its conclusive price hitting 50 $ETH. So, the NFT has effectively generated up to $208.56K in total valuation. Apart from that, CryptoPunk #8530 stands in the 7th position among the current month’s top NFT sales. Its price, which is 54 $ETH, equals a total $208.00K in valuation.

CryptoPunk #540 Bottoms List with 47 $ETH as Price

Moving on, Phoenix Group’s list of November’s top NFT sales adds CryptoPunk #7012 in the 8th place. As a result, to get this position, the NFT has generated 49 $ETH, adding $206.58K in price. The next top-sold NFT is CryptoPunk #8295, with its price touching 54.7 $ETH ($196.31K). Furthermore, CryptoPunk #540 has gained the 10th rank, getting 47 $ETH ($195.43K).

Market Opportunity
TOP Network Logo
TOP Network Price(TOP)
$0,000096
$0,000096$0,000096
0,00%
USD
TOP Network (TOP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26